Addex Therapeutics ADXN
NASDAQ ADXN
$3.07 +0.09 (+3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Addex Therapeutics' Depreciation & Amortization (CF) was $31,917 in Q2 2026, compared with $2,558 a year earlier and up 154.5% from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Addex Therapeutics' Depreciation & Amortization (CF) was $49,755 through Jun 30, 2026, down 47.0% year-over-year; for FY2025, it came in at $10,600, down 63.2% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -52.1% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $28,775 in FY2024 (-91.7%), $344,916 in FY2023 (+2.8%), $335,431 in FY2022 (-11.0%) and $376,987 in FY2021 (-10.0%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) since Q3 2024.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in 1 of the last seven quarters, with an average decline of 6.5%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2026 (growth of 432.3%); the worst was Q2 2025 (a decline of 97.9%).
  • Per Business Quant data, ADXN's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $12,540 (Q1 2026), $2,650 (Q4 2025) and $2,648 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Addex Therapeutics 2.67 Mn 2.67 Mn - 31,916.92
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31,916.92
Mar 31, 2026 12,540.19
Dec 31, 2025 2,649.98
Sep 30, 2025 2,647.73
Jun 30, 2025 2,558.31
Mar 31, 2025 2,355.75
Dec 31, 2024 27,171.64
Sep 30, 2024 61,836.65
Jun 30, 2024 124,271.28
Mar 31, 2024 80,610.21
Dec 31, 2023 89,495.03
Sep 30, 2023 85,342.79
Jun 30, 2023 83,865.82
Mar 31, 2023 81,929.42
Dec 31, 2022 78,524.28
Sep 30, 2022 80,059.44
Jun 30, 2022 86,537.57
Mar 31, 2022 94,022.42
Dec 31, 2021 89,976.80
Sep 30, 2021 95,558.01
API Access

Addex Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ADXN&period=max&api_key=YOUR_API_KEY